rs1557054873
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000033.4(ABCD1):c.1772G>A(p.Arg591Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R591P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000033.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCD1 | NM_000033.4 | c.1772G>A | p.Arg591Gln | missense_variant | Exon 7 of 10 | ENST00000218104.6 | NP_000024.2 | |
ABCD1 | XM_047441916.1 | c.2072G>A | p.Arg691Gln | missense_variant | Exon 8 of 11 | XP_047297872.1 | ||
LOC124905226 | XR_007068350.1 | n.837C>T | non_coding_transcript_exon_variant | Exon 1 of 2 | ||||
ABCD1 | XM_047441917.1 | c.*100G>A | downstream_gene_variant | XP_047297873.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCD1 | ENST00000218104.6 | c.1772G>A | p.Arg591Gln | missense_variant | Exon 7 of 10 | 1 | NM_000033.4 | ENSP00000218104.3 | ||
PLXNB3-AS1 | ENST00000434284.1 | n.72-2133C>T | intron_variant | Intron 1 of 2 | 3 | |||||
ABCD1 | ENST00000443684.2 | n.*107G>A | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 9.12e-7 AC: 1AN: 1096262Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 362870
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Adrenoleukodystrophy Pathogenic:6
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM1,PM2,PM5,PP2,PP3. -
Variant summary: ABCD1 c.1772G>A (p.Arg591Gln) results in a conservative amino acid change located in the ABC transporter-like, ATP-binding domain (IPR003439) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 182606 control chromosomes (gnomAD). c.1772G>A has been reported in the literature in individuals affected with Adrenoleukodystrophy (examples: Watkins_1995, Kok_1995, Jung_2012, Niu_2013). These data indicate that the variant is likely to be associated with disease. A different variant affecting this residue has been classified pathogenic in ClinVar (Variation ID: 92321). The following publications have been ascertained in the context of this evaluation (PMID: 23566833, 22280810, 17372139, 7581394, 7668254). ClinVar contains an entry for this variant (Variation ID: 458635). Based on the evidence outlined above, the variant was classified as pathogenic. -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 591 of the ABCD1 protein (p.Arg591Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with X-linked cerebellar adrenoleukodystrophy and adrenomyeloneuropathy (PMID: 7581394, 7668254, 19129531, 22280810, 23566833). ClinVar contains an entry for this variant (Variation ID: 458635). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ABCD1 protein function. Experimental studies have shown that this missense change affects ABCD1 function (PMID: 9425230). For these reasons, this variant has been classified as Pathogenic. -
Criteria applied: PS4,PM1,PM5,PM2_SUP,PP3 -
- -
- -
not provided Pathogenic:4
- -
Published functional studies found this variant is associated with significantly impaired beta-oxidation of VLCFA (PMID: 9425230); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 7668254, 17372139, 7581394, 23566833, 22280810, 33920672, 10551832, 35466195, 9425230, 32003821, 19129531) -
- -
- -
Inborn genetic diseases Pathogenic:1
The c.1772G>A (p.R591Q) alteration is located in exon 7 (coding exon 7) of the ABCD1 gene. This alteration results from a G to A substitution at nucleotide position 1772, causing the arginine (R) at amino acid position 591 to be replaced by a glutamine (Q). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant was identified in several individuals with X-linked adrenoleukodystrophy (ALD), including individuals with adrenomyeloneuropathy and adult cerebral ALD (Watkins, 1995; Costello, 2009; Niu, 2013; Lee, 2020). It was also identified in two symptomatic females with skewed X-inactivation (Jung, 2007; Salsano, 2012). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. -
Ehlers-Danlos syndrome, kyphoscoliotic type 1 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at